WebA phosphate binder (also referred to as a phosphorus binder) is a pill your doctor has prescribed to control the amount of phosphorus in your blood. You likely are given one of … WebApr 18, 2024 · All phosphate binders can have side effects, and most of these are gastrointestinal in nature, mainly consisting of nausea, diarrhoea or constipation. These side effects in general are self-limiting, usually after cessation of the offending compound.
Phosphate Binder - an overview ScienceDirect Topics
WebSep 25, 2015 · This calcium-free iron-based phosphate binder was approved in the United States by the US Food and Drug Administration (FDA) in November 2013 46,47 and in Europe by the European Medicines Agency (EMA) in August 2014 48 for the treatment of hyperphosphatemia in CKD patients receiving dialysis.. The final product is a chewable … Webdiscovered and developed by Ardelyx, is a first-in-class, targeted therapy for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. Tenapanor has a unique mechanism of action and acts locally in the gut to inhibit the sodium/hydrogen exchanger 3 (NHE3). trylon metal works lyndhurst nj
Sevelamer: Uses, Interactions, Mechanism of Action
WebJun 13, 2005 · Sevelamer is a phosphate binder used to treat hyperphosphatemia. Brand Names Renagel, Renvela Generic Name Sevelamer DrugBank Accession Number DB00658 Background Sevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. It is marketed by Genzyme under the trade name … WebMar 7, 2024 · Generic name: sevelamer [ se-VEL-a-mer ] Brand names: Renagel, Renvela Drug class: Phosphate binders Medically reviewed by Sanjai Sinha, MD. Last updated on … WebJul 19, 2024 · Drug Class: Iron Products, PO4 Scavengers; Medical Editor: John P. Cunha, DO, ... Auryxia (ferric citrate) is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney … phillip allmendinger